Robert Anthenelli

Title(s)Professor, Psychiatry
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
ORCID ORCID Icon0000000266121126 Additional info
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Biography

    Dr. Anthenelli is a Professor and the former Interim Chair, Executive Vice Chair, and Vice Chair for Veterans Affairs, respectively, in the UC San Diego Department of Psychiatry where he directs the Pacific Treatment and Research Center (Pac-TARC).

    He earned his baccalaureate degree from the Johns Hopkins University in Baltimore, Maryland, and his medical degree from the Johns Hopkins University School of Medicine. He completed his internship in internal medicine at Mercy Hospital in Baltimore, and his psychiatry residency training at UCSD and the San Diego Veterans Affairs Medical Center. Additional post-doctoral training included a two-year fellowship in addiction psychiatry research that was funded by the Department of Veterans Affairs.

    He was formerly a Professor of Psychiatry, Psychology and Neuroscience at the University of Cincinnati, College of Medicine where he founded and directed the Center for Treatment, Research & Education in Addictive Disorders and the Addiction Sciences Division. He also directed the Substance Dependence Program at the Cincinnati VA which was awarded the Department of Veterans Affairs, Under Secretary for Health’s Award as a Clinical Program of Excellence in Substance Abuse and was selected as a National Tobacco Cessation Clinical Resource Center.

    Dr. Anthenelli was the recipient of a Young Investigator Award from the American Society of Addiction Medicine and he has been selected among the Best Doctors and Top Psychiatrists in America. He is an Associate Editor of Current Psychiatry, and serves on the editorial advisory boards of the Journal of Addiction Medicine and Journal of Studies on Alcohol and Drugs.

    Research Interests

    The overarching theme of Dr. Anthenelli’s research is to develop improved treatments for tobacco, alcohol and stimulant dependence by better understanding the neurobiology of the disorders. He is the author or co-author of over 240 peer-reviewed articles, book chapters and published abstracts. Support for his research is provided by the National Institute on Alcohol Abuse and Alcoholism, National Institute on Drug Abuse, University of California Office of the President’s Tobacco-Related Disease Research Program, and various industry sponsors.

    Collapse Research 
    Collapse Research Activities and Funding
    Clinical development of an mGlu2 positive allosteric modulator to treat nicotine addiction
    NIH U01DA051077Aug 15, 2020 - Jul 31, 2023
    Role: Co-Principal Investigator
    Exploring Potential Sex Differences In Neurobiological Mechanisms of Alcohol Sensitivity and Tolerance
    NIH R21AA027634Mar 1, 2020 - Feb 28, 2022
    Role: Principal Investigator
    Wearable Biosensors for Real-time Blood Alcohol Monitoring
    NIH R44AA024643Sep 10, 2015 - Aug 31, 2019
    Role: Co-Principal Investigator
    New Pharmacotherapy for Alcohol and Co-morbid Disorders
    NIH R01AA019720Sep 10, 2010 - Aug 31, 2016
    Role: Co-Principal Investigator
    Predicting Alcoholics' Treatment Responses to an SSRI
    NIH R01AA013957May 1, 2004 - Apr 30, 2010
    Role: Principal Investigator
    Alcohol and Gender Effects on Stress Circuit Function
    NIH R01AA013307Sep 1, 2003 - Aug 31, 2009
    Role: Principal Investigator
    SCIENTIFIC REVIEW AND EVALUATION AWARD
    NIH U09AA012364Jan 1, 1999 - Sep 30, 2005
    Role: Principal Investigator
    CLINICALLY RELEVANT MARKERS OF ALCOHOLIC SUBGROUPS
    NIH R29AA009735Jul 1, 1993 - Jun 30, 1999
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Sex differences in alcohol's effects on fronto-amygdalar functional connectivity during processing of emotional stimuli. Alcohol Clin Exp Res (Hoboken). 2024 Apr; 48(4):612-622. McKenna BS, Anthenelli RM, Schuckit MA. PMID: 38379361; PMCID: PMC11015979.
      View in: PubMed   Mentions:    Fields:    
    2. Combining varenicline preloading with Acceptance and Commitment Therapy (ACT) in persons with serious mental illness who smoke: The randomized ACTSLow pilot feasibility trial. Drug Alcohol Depend. 2023 Dec 01; 253:111012. Anthenelli RM, McKenna BS, Giannini J, Attaluri SV, Rubin M, O'Crowley E, Miller S, Heffner JL. PMID: 37931328.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Sex effects in predictors of smoking abstinence and neuropsychiatric adverse events in the EAGLES trial. Drug Alcohol Depend Rep. 2023 Sep; 8:100177. McKee SA, Lawrence DE, Saccone P, McRae T, Anthenelli RM. PMID: 37520849; PMCID: PMC10372180.
      View in: PubMed   Mentions:
    4. The effects of varenicline, bupropion, nicotine patch, and placebo on smoking cessation among smokers with major depression: A randomized clinical trial. Depress Anxiety. 2022 05; 39(5):429-440. Cinciripini PM, Kypriotakis G, Green C, Lawrence D, Anthenelli RM, Minnix J, Blalock JA, Beneventi D, Morris C, Karam-Hage M. PMID: 35535436; PMCID: PMC9705120.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    5. Topiramate decreases the salience of motivationally relevant visual cues among smokers with alcohol use disorder. Alcohol Clin Exp Res. 2022 03; 46(3):384-395. Robinson JD, Cui Y, Karam-Hage M, Kypriotakis G, Versace F, Ait-Daoud Tiouririne N, Anthenelli RM, Cinciripini PM. PMID: 35037278; PMCID: PMC8920769.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    6. Low versus high level of response to alcohol affects amygdala functional connectivity during processing of emotional stimuli. Alcohol Clin Exp Res. 2022 01; 46(1):66-76. McKenna BS, Anthenelli RM, Smith TL, Schuckit MA. PMID: 35064942; PMCID: PMC8820383.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    7. Psychiatric Comorbidity and Multimorbidity in the EAGLES Trial: Descriptive Correlates and Associations With Neuropsychiatric Adverse Events, Treatment Adherence, and Smoking Cessation. Nicotine Tob Res. 2021 08 29; 23(10):1646-1655. Correa JB, Lawrence D, McKenna BS, Gaznick N, Saccone PA, Dubrava S, Doran N, Anthenelli RM. PMID: 33788933; PMCID: PMC8521682.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    8. Relationship between level of response to alcohol and acute tolerance. Alcohol Clin Exp Res. 2021 07; 45(7):1504-1513. Anthenelli RM, McKenna BS, Smith TL, Schuckit MA. PMID: 34086362.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    9. Behavioral Economic Assessment of Alcohol and Cigarette Demand in Smokers With Alcohol Use Disorder. Front Psychiatry. 2021; 12:674607. Cui Y, Linares Abrego P, Yoon JH, Karam-Hage M, Cinciripini PM, Ait-Daoud Tiouririne N, Anthenelli RM, Robinson JD. PMID: 34248711; PMCID: PMC8260696.
      View in: PubMed   Mentions: 2  
    10. Estimation of risk of neuropsychiatric adverse events from varenicline, bupropion and nicotine patch versus placebo: secondary analysis of results from the EAGLES trial using Bayes factors. Addiction. 2021 10; 116(10):2816-2824. Beard E, Jackson SE, Anthenelli RM, Benowitz NL, Aubin LS, McRae T, Lawrence D, Russ C, Krishen A, Evins AE, West R. PMID: 33885203; PMCID: PMC8612131.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    11. Efficacy and Safety of Pharmacotherapeutic Smoking Cessation Aids in Schizophrenia Spectrum Disorders: Subgroup Analysis of EAGLES. Psychiatr Serv. 2021 01 01; 72(1):7-15. Evins AE, West R, Benowitz NL, Russ C, Lawrence D, McRae T, Maravic MC, Heffner JL, Anthenelli RM. PMID: 33138708; PMCID: PMC10228639.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    12. Efficacy and safety of pharmacotherapies for smoking cessation in anxiety disorders: Subgroup analysis of the randomized, active- and placebo-controlled EAGLES trial. Depress Anxiety. 2020 03; 37(3):247-260. Ayers CR, Heffner JL, Russ C, Lawrence D, McRae T, Evins AE, Anthenelli RM. PMID: 31850603; PMCID: PMC7064930.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    13. Safety and efficacy of first-line smoking cessation pharmacotherapies in bipolar disorders: Subgroup analysis of a randomized clinical trial. J Affect Disord. 2019 09 01; 256:267-277. Heffner JL, Evins AE, Russ C, Lawrence D, Ayers CR, McRae T, Aubin LS, Krishen A, West R, Anthenelli RM. PMID: 31195244; PMCID: PMC8936081.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    14. Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES Trial. J Gen Intern Med. 2019 06; 34(6):862-870. Anthenelli RM, Gaffney M, Benowitz NL, West R, McRae T, Russ C, Lawrence D, St Aubin L, Krishen A, Evins AE. PMID: 30847828; PMCID: PMC6544691.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    15. Neuropsychiatric Safety and Efficacy of Varenicline, Bupropion, and Nicotine Patch in Smokers With Psychotic, Anxiety, and Mood Disorders in the EAGLES Trial. J Clin Psychopharmacol. 2019 Mar/Apr; 39(2):108-116. Evins AE, Benowitz NL, West R, Russ C, McRae T, Lawrence D, Krishen A, St Aubin L, Maravic MC, Anthenelli RM. PMID: 30811371; PMCID: PMC6488024.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    16. Effects of Varenicline, Depressive Symptoms, and Region of Enrollment on Smoking Cessation in Depressed Smokers. Nicotine Tob Res. 2019 01 04; 21(2):156-162. Doran N, Dubrava S, Anthenelli RM. PMID: 29471329; PMCID: PMC6329403.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    17. Predictors of reduced smoking quantity among recovering alcohol dependent men in a smoking cessation trial. Addict Behav. 2018 09; 84:263-270. Worley MJ, Isgro M, Heffner JL, Lee SY, Daniel BE, Anthenelli RM. PMID: 29763835; PMCID: PMC6357959.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. Sex differences in the ACTH and cortisol response to pharmacological probes are stressor-specific and occur regardless of alcohol dependence history. Psychoneuroendocrinology. 2018 08; 94:72-82. Anthenelli RM, Heffner JL, Blom TJ, Daniel BE, McKenna BS, Wand GS. PMID: 29763783; PMCID: PMC6411284.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    19. Cardiovascular Safety of Varenicline, Bupropion, and Nicotine Patch in Smokers: A Randomized Clinical Trial. JAMA Intern Med. 2018 05 01; 178(5):622-631. Benowitz NL, Pipe A, West R, Hays JT, Tonstad S, McRae T, Lawrence D, St Aubin L, Anthenelli RM. PMID: 29630702; PMCID: PMC6145797.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    20. Factors associated with the efficacy of smoking cessation treatments and predictors of smoking abstinence in EAGLES. Addiction. 2018 08; 113(8):1507-1516. West R, Evins AE, Benowitz NL, Russ C, McRae T, Lawrence D, St Aubin L, Krishen A, Maravic MC, Anthenelli RM. PMID: 29508470; PMCID: PMC6055735.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    21. "I Smoke Like This to Suppress These Issues That Are Flaws of My Character": Challenges and Facilitators of Cessation Among Smokers With Bipolar Disorder. J Dual Diagn. 2018 Jan-Mar; 14(1):32-39. Heffner JL, Watson NL, McClure JB, Anthenelli RM, Hohl S, Bricker JB. PMID: 29351507; PMCID: PMC5995156.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    22. Co-Occurring Alcohol Use Disorder and Post-Traumatic Stress Disorder. Alcohol Res. 2018; 39(2):111-112. Anthenelli RM, Brady KT, Grandison L, Roach D. PMID: 31198650; PMCID: PMC6561396.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    23. Metabotropic Glutamate Receptors 2 and 3 as Targets for Treating Nicotine Addiction. Biol Psychiatry. 2018 06 01; 83(11):947-954. Cross AJ, Anthenelli R, Li X. PMID: 29301614; PMCID: PMC5953779.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimals
    24. Alcohol-related blackouts among college students: impact of low level of response to alcohol, ethnicity, sex, and environmental characteristics. Braz J Psychiatry. 2018 Apr-June; 40(2):128-137. Gonçalves PD, Smith TL, Anthenelli RM, Danko G, Schuckit MA. PMID: 28876407; PMCID: PMC6900764.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    25. Blunted amygdala functional connectivity during a stress task in alcohol dependent individuals: A pilot study. Neurobiol Stress. 2017 Dec; 7:74-79. Wade NE, Padula CB, Anthenelli RM, Nelson E, Eliassen J, Lisdahl KM. PMID: 28626785; PMCID: PMC5466595.
      View in: PubMed   Mentions: 5  
    26. A Prospective Comparison of How the Level of Response to Alcohol and Impulsivity Relate to Future DSM-IV Alcohol Problems in the COGA Youth Panel. Alcohol Clin Exp Res. 2017 Jul; 41(7):1329-1339. Schuckit MA, Smith TL, Danko G, Anthenelli R, Schoen L, Kawamura M, Kramer J, Dick DM, Neale Z, Kuperman S, McCutcheon V, Anokhin AP, Hesselbrock V, Hesselbrock M, Bucholz K. PMID: 28440866; PMCID: PMC5512427.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    27. Pooled analysis of three randomized, double-blind, placebo controlled trials with rimonabant for smoking cessation. Addict Biol. 2018 01; 23(1):291-303. Robinson JD, Cinciripini PM, Karam-Hage M, Aubin HJ, Dale LC, Niaura R, Anthenelli RM, STRATUS Group. PMID: 28429843; PMCID: PMC5912319.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    28. Type A/Type B Alcoholism Predicts Differential Response to Topiramate in a Smoking Cessation Trial in Dually Diagnosed Men. J Stud Alcohol Drugs. 2017 03; 78(2):232-240. Isgro M, Doran N, Heffner JL, Wong E, Dinh E, Tibbs J, Russell K, Bittner T, Wehrle C, Worley MJ, Anthenelli RM. PMID: 28317503; PMCID: PMC5554104.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    29. Predictors of Patterns of Alcohol-Related Blackouts Over Time in Youth From the Collaborative Study of the Genetics of Alcoholism: The Roles of Genetics and Cannabis. J Stud Alcohol Drugs. 2017 01; 78(1):39-48. Schuckit MA, Smith TL, Shafir A, Clausen P, Danko G, Gonçalves PD, Anthenelli RM, Chan G, Kuperman S, Hesselbrock M, Hesselbrock V, Kramer J, Bucholz KK. PMID: 27936363; PMCID: PMC5148748.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    30. A Randomized Trial Evaluating Whether Topiramate Aids Smoking Cessation and Prevents Alcohol Relapse in Recovering Alcohol-Dependent Men. Alcohol Clin Exp Res. 2017 01; 41(1):197-206. Anthenelli RM, Heffner JL, Wong E, Tibbs J, Russell K, Isgro M, Dinh E, Wehrle C, Worley MJ, Doran N. PMID: 28029173; PMCID: PMC5310526.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    31. Alcohol-related blackouts across 55 weeks of college: Effects of European-American ethnicity, female sex, and low level of response to alcohol. Drug Alcohol Depend. 2016 Dec 01; 169:163-170. Schuckit MA, Smith TL, Goncalves PD, Anthenelli R. PMID: 27835824; PMCID: PMC5140721.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    32. Smokers with Self-Reported Mental Health Conditions: A Case for Screening in the Context of Tobacco Cessation Services. PLoS One. 2016; 11(7):e0159127. Tedeschi GJ, Cummins SE, Anderson CM, Anthenelli RM, Zhuang YL, Zhu SH. PMID: 27391334; PMCID: PMC4938618.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    33. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet. 2016 Jun 18; 387(10037):2507-20. Anthenelli RM, Benowitz NL, West R, St Aubin L, McRae T, Lawrence D, Ascher J, Russ C, Krishen A, Evins AE. PMID: 27116918.
      View in: PubMed   Mentions: 333     Fields:    Translation:Humans
    34. Acceptance and Commitment Therapy and nicotine patch for smokers with bipolar disorder: preliminary evaluation of in-person and telephone-delivered treatment. Bipolar Disord. 2015 Aug; 17(5):560-6. Heffner JL, McClure JB, Mull KE, Anthenelli RM, Bricker JB. PMID: 25912192; PMCID: PMC4526426.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    35. Gender effects in alcohol dependence: an fMRI pilot study examining affective processing. Alcohol Clin Exp Res. 2015 Feb; 39(2):272-81. Padula CB, Anthenelli RM, Eliassen JC, Nelson E, Lisdahl KM. PMID: 25684049; PMCID: PMC5303611.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    36. Risk and protective factors associated with substance use disorders in adolescents with first-episode mania. J Am Acad Child Adolesc Psychiatry. 2014 Jul; 53(7):771-9. Stephens JR, Heffner JL, Adler CM, Blom TJ, Anthenelli RM, Fleck DE, Welge JA, Strakowski SM, DelBello MP. PMID: 24954826; PMCID: PMC4288812.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    37. Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial. Ann Intern Med. 2013 Sep 17; 159(6):390-400. Anthenelli RM, Morris C, Ramey TS, Dubrava SJ, Tsilkos K, Russ C, Yunis C. PMID: 24042367.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansCTClinical Trials
    38. Mood management and nicotine patch for smoking cessation in adults with bipolar disorder. Nicotine Tob Res. 2013 Nov; 15(11):1805-6. Heffner JL, Anthenelli RM, DelBello MP, Stahl L, Strakowski SM. PMID: 23766341; PMCID: PMC3790632.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    39. Prevalence and correlates of heavy smoking and nicotine dependence in adolescents with bipolar and cannabis use disorders. Psychiatry Res. 2013 Dec 30; 210(3):857-62. Heffner JL, Anthenelli RM, Adler CM, Strakowski SM, Beavers J, DelBello MP. PMID: 23684537; PMCID: PMC3899029.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    40. A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry. 2012 May; 73(5):654-60. Williams JM, Anthenelli RM, Morris CD, Treadow J, Thompson JR, Yunis C, George TP. PMID: 22697191.
      View in: PubMed   Mentions: 66     Fields:    Translation:Humans
    41. Diagnosing Alcohol and Cannabis Use Disorders in Adolescents with Bipolar Disorder: A Preliminary Investigation. J Dual Diagn. 2012 Jan; 8(1):13-18. Black JJ, Heffner JL, Anthenelli RM, Beavers JN, Albertz A, Blom T, Adler C, Delbello MP. PMID: 23087600; PMCID: PMC3475180.
      View in: PubMed   Mentions: 4     Fields:    
    42. Cigarette smoking and its relationship to mood disorder symptoms and co-occurring alcohol and cannabis use disorders following first hospitalization for bipolar disorder. Bipolar Disord. 2012 Feb; 14(1):99-108. Heffner JL, DelBello MP, Anthenelli RM, Fleck DE, Adler CM, Strakowski SM. PMID: 22329477; PMCID: PMC3281507.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    43. Overview: stress and alcohol use disorders revisited. Alcohol Res. 2012; 34(4):386-90. Anthenelli RM. PMID: 23584104; PMCID: PMC3860385.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    44. Effects of stress on alcohol consumption. Alcohol Res. 2012; 34(4):381-2. Anthenelli R, Grandison L. PMID: 23729049; PMCID: PMC3860387.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    45. Childhood adversity, serotonin transporter (5-HTTLPR) genotype, and risk for cigarette smoking and nicotine dependence in alcohol dependent adults. Drug Alcohol Depend. 2012 Jun 01; 123(1-3):201-6. Mingione CJ, Heffner JL, Blom TJ, Anthenelli RM. PMID: 22172222; PMCID: PMC3315603.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    46. Selegiline transdermal system (STS) as an aid for smoking cessation. Nicotine Tob Res. 2012 Mar; 14(3):377-82. Kahn R, Gorgon L, Jones K, McSherry F, Glover ED, Anthenelli RM, Jackson T, Williams J, Murtaugh C, Montoya I, Yu E, Elkashef A. PMID: 21846661; PMCID: PMC3281235.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    47. The co-occurrence of cigarette smoking and bipolar disorder: phenomenology and treatment considerations. Bipolar Disord. 2011 Aug-Sep; 13(5-6):439-53. Heffner JL, Strawn JR, DelBello MP, Strakowski SM, Anthenelli RM. PMID: 22017214; PMCID: PMC3729285.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    48. Gender differences in trauma history and symptoms as predictors of relapse to alcohol and drug use. Am J Addict. 2011 Jul-Aug; 20(4):307-11. Heffner JL, Blom TJ, Anthenelli RM. PMID: 21679261; PMCID: PMC3126098.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansPHPublic Health
    49. Smoking history, nicotine dependence, and changes in craving and mood during short-term smoking abstinence in alcohol dependent vs. control smokers. Addict Behav. 2011 Mar; 36(3):244-7. Heffner JL, Mingione C, Blom TJ, Anthenelli RM. PMID: 21106299; PMCID: PMC3021180.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    50. Exposure to traumatic events among treatment-seeking, alcohol-dependent women and men without PTSD. J Trauma Stress. 2010 Oct; 23(5):649-52. Johnson CS, Heffner JL, Blom TJ, Anthenelli RM. PMID: 20803578; PMCID: PMC3970570.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    51. Relationship between the serotonin transporter polymorphism and obsessive-compulsive alcohol craving in alcohol-dependent adults: a pilot study. Alcohol. 2010 Aug; 44(5):401-6. Thompson RD, Heffner JL, Strong JA, Blom TJ, Anthenelli RM. PMID: 20598843; PMCID: PMC2932830.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    52. Relationship between cigarette smoking and childhood symptoms of inattention and hyperactivity/impulsivity in alcohol-dependent adults without attention-deficit hyperactivity disorder. Nicotine Tob Res. 2010 Mar; 12(3):243-50. Heffner JL, Johnson CS, Blom TJ, Anthenelli RM. PMID: 20083646; PMCID: PMC2825102.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    53. Predictors of post-treatment relapse to smoking in successful quitters: pooled data from two phase III varenicline trials. Drug Alcohol Depend. 2010 Jun 01; 109(1-3):120-5. Heffner JL, Lee TC, Arteaga C, Anthenelli RM. PMID: 20071105; PMCID: PMC2875368.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    54. Combining motivational interviewing with compliance enhancement therapy (MI-CET): development and preliminary evaluation of a new, manual-guided psychosocial adjunct to alcohol-dependence pharmacotherapy. J Stud Alcohol Drugs. 2010 Jan; 71(1):61-70. Heffner JL, Tran GQ, Johnson CS, Barrett SW, Blom TJ, Thompson RD, Anthenelli RM. PMID: 20105415; PMCID: PMC2815064.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    55. Focus on: Comorbid mental health disorders. Alcohol Res Health. 2010; 33(1-2):109-17. Anthenelli RM. PMID: 23579941; PMCID: PMC3887501.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimals
    56. Cigarette smoking in the early course of bipolar disorder: association with ages-at-onset of alcohol and marijuana use. Bipolar Disord. 2008 Nov; 10(7):838-45. Heffner JL, DelBello MP, Fleck DE, Anthenelli RM, Strakowski SM. PMID: 19032716.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    57. Tricyclic antidepressant immunoassays may reflect quetiapine adherence. Am J Psychiatry. 2008 Jul; 165(7):919-20. Cerullo MA, Albertz AA, Bell JN, Anthenelli RM, Delbello MP. PMID: 18593795; PMCID: PMC2631408.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    58. Preliminary evidence for gender-specific effects of topiramate as a potential aid to smoking cessation. Addiction. 2008 Apr; 103(4):687-94. Anthenelli RM, Blom TJ, McElroy SL, Keck PE. PMID: 18339115.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    59. Interrelated effects of substance use diagnosis, race, and smoking severity on abstinence initiation in dually dependent male smokers: results of a retrospective chart review. J Addict Med. 2007 Dec; 1(4):191-7. Heffner JL, Blom TJ, Camerota E, Sansone LE, Bodie L, Smith J, Lin S, Drake JM, Meyer C, Anthenelli RM. PMID: 21768957.
      View in: PubMed   Mentions: 1     Fields:    
    60. A call to action: new treatment options provide even more reasons to intervene in tobacco dependence. Nat Clin Pract Cardiovasc Med. 2007 Sep; 4(9):462-3. Anthenelli RM. PMID: 17646852.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    61. Predicting alcohol misusers' readiness and ability to quit smoking: a critical review. Alcohol Alcohol. 2007 May-Jun; 42(3):186-95. Heffner JL, Barrett SW, Anthenelli RM. PMID: 17526628.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    62. Effects of co-occurring cannabis use disorders on the course of bipolar disorder after a first hospitalization for mania. Arch Gen Psychiatry. 2007 Jan; 64(1):57-64. Strakowski SM, DelBello MP, Fleck DE, Adler CM, Anthenelli RM, Keck PE, Arnold LM, Amicone J. PMID: 17199055.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansPHPublic Health
    63. Sertraline treatment of co-occurring alcohol dependence and major depression. J Clin Psychopharmacol. 2006 Feb; 26(1):13-20. Kranzler HR, Mueller T, Cornelius J, Pettinati HM, Moak D, Martin PR, Anthenelli R, Brower KJ, O'Malley S, Mason BJ, Hasin D, Keller M. PMID: 16415699.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCTClinical Trials
    64. Expanding treatment of tobacco dependence. Curr Psychiatry Rep. 2005 Oct; 7(5):344-51. Harris DS, Anthenelli RM. PMID: 16216152.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    65. Effects of co-occurring alcohol abuse on the course of bipolar disorder following a first hospitalization for mania. Arch Gen Psychiatry. 2005 Aug; 62(8):851-8. Strakowski SM, DelBello MP, Fleck DE, Adler CM, Anthenelli RM, Keck PE, Arnold LM, Amicone J. PMID: 16061762.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    66. Sex differences in spatial visualization and episodic memory as a function of alcohol consumption. Alcohol Alcohol. 2005 May-Jun; 40(3):201-7. Yonker JE, Nilsson LG, Herlitz A, Anthenelli RM. PMID: 15797882.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    67. Alcohol use, cognitive correlates of drinking and change readiness in hazardous drinkers with high versus low social anxiety. J Stud Alcohol. 2004 Nov; 65(6):715-24. Tran GQ, Anthenelli RM, Smith JP, Corcoran KJ, Rofey DL. PMID: 15700508.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    68. A multi-site dose ranging study of nalmefene in the treatment of alcohol dependence. J Clin Psychopharmacol. 2004 Aug; 24(4):421-8. Anton RF, Pettinati H, Zweben A, Kranzler HR, Johnson B, Bohn MJ, McCaul ME, Anthenelli R, Salloum I, Galloway G, Garbutt J, Swift R, Gastfriend D, Kallio A, Karhuvaara S. PMID: 15232334.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCTClinical Trials
    69. Brief integrated outpatient dual-diagnosis treatment reduces psychiatric hospitalizations. Am J Addict. 2003 Jul-Sep; 12(4):306-13. Granholm E, Anthenelli R, Monteiro R, Sevcik J, Stoler M. PMID: 14504023.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    70. Independent alcohol and tobacco effects on stress axis function. Alcohol Clin Exp Res. 2002 Dec; 26(12):1932-3. Anthenelli RM, Maxwell RA. PMID: 12500125.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    71. Intra- and inter-individual relationships between central and peripheral serotonergic activity in humans: a serial cerebrospinal fluid sampling study. Life Sci. 2002 Jul 26; 71(10):1219-25. Strawn JR, Ekhator NN, Anthenelli RM, Baker DG, Maxwell RA, Hill KK, Geracioti TD. PMID: 12095542.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    72. A bootstrapped commingling analysis of platelet monoamine oxidase activity levels corrected for cigarette smoking. Psychiatr Genet. 2001 Dec; 11(4):177-85. Daw EW, Rice JP, Anthenelli RM, Schuckit MA, Tipp J, Saccone NL, Reich T, Nurnberger JI, Li TK. PMID: 11807407.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    73. Stress hormone dysregulation at rest and after serotonergic stimulation among alcohol-dependent men with extended abstinence and controls. Alcohol Clin Exp Res. 2001 May; 25(5):692-703. Anthenelli RM, Maxwell RA, Geracioti TD, Hauger R. PMID: 11411461.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    74. Monoamine oxidases and tobacco smoking. Int J Neuropsychopharmacol. 2001 Mar; 4(1):33-42. Berlin I, Anthenelli RM. PMID: 11343627.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansAnimals
    75. Cigarette smoking decreases the prolactin response to serotonergic stimulation in subgroups of alcoholics and controls. Alcohol Clin Exp Res. 2000 Jul; 24(7):987-95. Anthenelli RM, Maxwell RA. PMID: 10924001.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    76. Use of health services by men with and without antisocial personality disorder who are alcohol dependent. Psychiatr Serv. 2000 Mar; 51(3):380-2. Murray MG, Anthenelli RM, Maxwell RA. PMID: 10686248.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    77. Platelet monoamine oxidase activity in subgroups of alcoholics and controls: results from the Collaborative Study on the Genetics of Alcoholism. Alcohol Clin Exp Res. 1998 May; 22(3):598-604. Anthenelli RM, Tipp J, Li TK, Magnes L, Schuckit MA, Rice J, Daw W, Nurnberger JI. PMID: 9622437.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    78. Cerebrospinal fluid neuroendocrinology of alcohol misusers. Addict Biol. 1997 Oct; 2(4):401-10. Geracioti TD, Goldsmith RJ, Friedman LM, Norman AB, Somoza E, Kasckow JW, Baker DG, Richtand NM, Anthenelli RM, Keck PE. PMID: 26735945.
      View in: PubMed   Mentions:    Fields:    
    79. Alcohol challenges in young men from alcoholic pedigrees and control families: a report from the COGA project. J Stud Alcohol. 1996 Jul; 57(4):368-77. Schuckit MA, Tsuang JW, Anthenelli RM, Tipp JE, Nurnberger JI. PMID: 8776678.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCTClinical Trials
    80. Anorexia nervosa and bulimia nervosa in alcohol-dependent men and women and their relatives. Am J Psychiatry. 1996 Jan; 153(1):74-82. Schuckit MA, Tipp JE, Anthenelli RM, Bucholz KK, Hesselbrock VM, Nurnberger JI. PMID: 8540597.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    81. Platelet monoamine oxidase activity levels in subgroups of alcoholics: diagnostic, temporal, and clinical correlates. Biol Psychiatry. 1995 Sep 15; 38(6):361-8. Anthenelli RM, Smith TL, Craig CE, Tabakoff B, Schuckit MA. PMID: 8547455.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsCTClinical Trials
    82. The prevalence of major anxiety disorders in relatives of alcohol dependent men and women. J Stud Alcohol. 1995 May; 56(3):309-17. Schuckit MA, Hesselbrock VM, Tipp J, Nurnberger JI, Anthenelli RM, Crowe RR. PMID: 7623470.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    83. The time course of development of alcohol-related problems in men and women. J Stud Alcohol. 1995 Mar; 56(2):218-25. Schuckit MA, Anthenelli RM, Bucholz KK, Hesselbrock VM, Tipp J. PMID: 7760569.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    84. The Search for Biochemical Markers. Alcohol Health Res World. 1995; 19(3):176-181. Anthenelli RM, Tabakoff B. PMID: 31798085; PMCID: PMC6875761.
      View in: PubMed   Mentions: 1     Fields:    
    85. A comparison of DSM-III-R, DSM-IV and ICD-10 substance use disorders diagnoses in 1922 men and women subjects in the COGA study. Collaborative Study on the Genetics of Alcoholism. Addiction. 1994 Dec; 89(12):1629-38. Schuckit MA, Hesselbrock V, Tipp J, Anthenelli R, Bucholz K, Radziminski S. PMID: 7866247.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    86. A comparative study of criteria for subgrouping alcoholics: the primary/secondary diagnostic scheme versus variations of the type 1/type 2 criteria. Am J Psychiatry. 1994 Oct; 151(10):1468-74. Anthenelli RM, Smith TL, Irwin MR, Schuckit MA. PMID: 8092340.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    87. The prognostic importance of blackouts in young men. J Stud Alcohol. 1994 May; 55(3):290-5. Anthenelli RM, Klein JL, Tsuang JW, Smith TL, Schuckit MA. PMID: 8022176.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    88. Predictors of drinking and driving in healthy young men: a prospective study. Am J Drug Alcohol Abuse. 1994; 20(2):223-35. Klein JL, Anthenelli RM, Bacon NM, Smith TL, Schuckit MA. PMID: 8042604.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    89. Clinical course of alcoholism in 636 male inpatients. Am J Psychiatry. 1993 May; 150(5):786-92. Schuckit MA, Smith TL, Anthenelli R, Irwin M. PMID: 8480826.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    90. Affective and anxiety disorders and alcohol and drug dependence: diagnosis and treatment. J Addict Dis. 1993; 12(3):73-87. Anthenelli RM, Schuckit MA. PMID: 8251547.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    91. Amnestic effects of intravenous diazepam in healthy young men. Am J Drug Alcohol Abuse. 1991 Jun; 17(2):129-36. Anthenelli RM, Monteiro MG, Blunt B, Schuckit MA. PMID: 1862787.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    92. Genetic studies of alcoholism. Int J Addict. 1990-1991; 25(1A):81-94. Anthenelli RM, Schuckit MA. PMID: 2246085.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    93. The role of oxygen-free radicals in ischemic tissue injury in island skin flaps. Ann Surg. 1983 Jul; 198(1):87-90. Manson PN, Anthenelli RM, Im MJ, Bulkley GB, Hoopes JE. PMID: 6859996; PMCID: PMC1352938.
      View in: PubMed   Mentions: 30     Fields:    Translation:Animals
    94. Skin-flap metabolism in rats: oxygen consumption and lactate production. Plast Reconstr Surg. 1983 May; 71(5):685-8. Im MJ, Su CT, Hoopes JE, Anthenelli RM. PMID: 6340141.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    Robert's Networks
    Concepts (290)
    Derived automatically from this person's publications.
    _
    Co-Authors (15)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _